Mizuho Securities’s Novavax NVAX Stock Holding History

Mizuho Securities’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-25	Closed	–	–	158
2022 Q3	$0	Sell	25 -1	-4%	-$43	﹤0.01%	214
2022 Q2	$4K	Buy	26 +1	+4%	+$52	﹤0.01%	170
2022 Q1	$2K	Hold	25	–	–	﹤0.01%	188
2021 Q4	$4K	Buy	+25	New	+$4.3K	﹤0.01%	165

Other funds holding NVAX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

HIG

Herr Investment Group Austin, Texas $1.5B AUM 29.27% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Mizuho Securities's NVAX Position: Q4 2022 in Review

Mizuho Securities sold out of Novavax (NVAX) in Q4 2022, closing a stake of 25 shares.

Mizuho Securities first reported a position in NVAX in Q4 2021 and held it in 4 quarters. The position peaked at $4K in Q2 2022. 252 funds tracked by Wall St. Rank hold NVAX as of Q4 2022.

Mizuho Securities reported no remaining Novavax position as of Q4 2022 after selling out during the quarter.
Mizuho Securities sold 25 Novavax shares in Q4 2022.
Mizuho Securities first reported a position in Novavax in Q4 2021 and held it in 4 quarters.
Mizuho Securities's Novavax position peaked at $4K in Q2 2022.
252 funds tracked by Wall St. Rank held Novavax as of Q4 2022.

Based on Mizuho Securities's 13F filing for Q4 2022, filed 7 Feb 2023.